212688-02-3

Basic information

• Product Name: METHYL-3,5-DIBROMO-4-HYDROXYPHENYLACETATE
• Synonyms: METHYL-3,5-DIBROMO-4-HYDROXYPHENYLACETATE;Methyl 2-(3,5-dibroMo-4-hydroxyphenyl)acetate;ethyl 2-(3,5-dibromo-4-hydroxyphenyl)acetate;Methyl 2-(3,5-dibromo-4-hydroxyphenyl);Methyl 2-(3,5-Dibromo-4-Hydroxyphenyl)Acetate(WXC02347)
• CAS NO: 212688-02-3
• Molecular Formula: C₉H₈Br₂O₃
• Molecular Weight: 323.97
• Mol File: 212688-02-3.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL-3,5-DIBROMO-4-HYDROXYPHENYLACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-3,5-DIBROMO-4-HYDROXYPHENYLACETATE(212688-02-3)
• EPA Substance Registry System: METHYL-3,5-DIBROMO-4-HYDROXYPHENYLACETATE(212688-02-3)

Safety Data

• Hazardous Substances Data: 212688-02-3(Hazardous Substances Data)

Usage

General Description

Methyl-3,5-dibromo-4-hydroxyphenylacetate is a chemical compound that belongs to the class of phenylacetates. It is a methyl ester derivative of 3,5-dibromo-4-hydroxyphenylacetic acid, which is a brominated derivative of phenylacetic acid. METHYL-3,5-DIBROMO-4-HYDROXYPHENYLACETATE is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has also been studied for its potential antimicrobial and antioxidant properties. Overall, methyl-3,5-dibromo-4-hydroxyphenylacetate has a range of potential applications in various industries due to its unique chemical properties.

Upstream product

• 67-56-1 methanol 
• 24744-58-9 (3,5-dibromo-4-hydroxyphenyl)acetic acid 
• 14199-15-6 Methyl 4-hydroxyphenylacetate 
• 156-38-7 4-hydroxyphenylacetate 

Downstream Products

• 89936-29-8 2-(3,5-dibromo-4-methoxyphenyl)acetic acid 
• 212688-03-4 3,5-dibromo-4-methoxy-phenyl acetic acid methyl ester 
• 86255-01-8 4-<(ethoxycarbonyl)methyl>-2,6-dibromo-4-hydroxycyclohexadienone 
• 219692-15-6 (3,5-dibromo-4-(5-isopropyl-4-methoxy-phenoxy)-phenyl)-acetic acid methyl ester 
• 348167-06-6 3,5-Dibromo-4-(4-methoxyphenoxy)phenylacetic acid methyl ester 
• 958255-18-0 3,5-dibromo-4-{[tert-butyl(dimethyl)silyl]oxy}phenylacetic acid methyl ester 
• 958255-19-1 2-[3,5-dibromo-4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-ethanol 
• 958255-20-4 [4-(2-azido-ethyl)-2,6-dibromo-phenoxy]-tert-butyl-dimethyl-silane 
• 958255-23-7 {3-[4-(2-amino-ethyl)-2,6-dibromo-phenoxy]-propyl}-methyl-carbamic acid methyl ester 
• 958255-27-1 methanesulfonic acid 2-[3,5-dibromo-4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-ethyl ester 
• 958255-21-5 {2-[3,5-dibromo-4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-ethyl}-carbamic acid tert-butyl ester 
• 958255-22-6 {3-[2,6-dibromo-4-(2-tert-butoxycarbonylamino-ethyl)-phenoxy]-propyl}-methyl-carbamic acid methyl ester 
• 210880-88-9 N-(tert-butoxycarbonyl)-3,5-dibromo-4-hydroxy-β-phenethylamine 

Relevant articles and documents

Synthesis of (+)-O-methylthalibrine by employing a stereocontrolled Bischler-Napieralski reaction and an electrochemically generated diaryl ether

An efficient electrochemical four-step route was developed for the preparation of diaryl ether derivatives by using halogenation and dehalogenation processes in addition to electrochemical phenolic oxidation and reduction reactions. The synthesis of (+)-O

Total synthesis of antibacterial dibromotyrosine derived alkaloid purpuramine-K#

The first total synthesis of a dibromotyrosine derived alkaloid purpuramine K 1 reported for possible anti-bacterial activity against gram-positive bacteria viz: Staphylococcus aureus, Bacillus subtilis, Bacillus sphaericus and gram-negative bacteria like Chromobacterium violaceum, Klebsiella aerogenes, and Pseudomonas aeruginosa has been achieved. The synthesis involves preparation of methyl-3-bromopropyl carbamate 6, and Boc protected 2-[3,5-dibromo, 4-hydroxy phenyl] ethyl amine 13 which is followed by coupling of these two structural fragments to give corresponding ether 14. After deprotection of Boc group in compound 14, it is reacted with 4-hydroxyphenyl pyruvic acid oxime derivative 17 using EDCI/HOBT to give compound 18, which is further transformed to purpuramine K.

Thyroid receptor ligands and method

Novel thyroid receptor ligands are provided which have the general formula (I) where R1is alkyl of 1 to 4 carbons or cycloalkyl of 3 to 7 carbons; R2and R3are the same or different and are hydrogen, halogen, alkyl of 1 to